MediVas LLC Company Profile

Using its proprietary family of biodegradable and biocompatible polymers, MediVas has developed unique platforms for the delivery of biologics. MediVas is utilizing its novel polymer technology in collaboration with some of the world's largest pharmaceutical companies, as well as on its own internal product development efforts, to create groundbreaking medical advancements. By combining therapeutic proteins and other biologics with a MediVas polymer, delivery routes that were previously unattainable, such as oral, intranasal, inhaled or subcutaneous injection, can now be achieved. With these routes of delivery then available, MediVas' delivery system can make the administration of the biologic more convenient, more efficacious and safer, leading to higher patientcompliance and overall better health. For more information visit www.medivas.com or contact Joseph Dowling at +1 (858) 622-2005.

News Articles
[0 Results]

None

Drugs and Medications
[0 Results]

None

PubMed Articles
[0 Results]

None

Clinical Trials
[0 Results]

Since our founding in 1998, we at MediVas have had one simple goal - to change the way that pharmaceuticals are delivered. From small molecule drugs to whole proteins, MediVas has developed a novel pl...

Using its proprietary family of biodegradable and biocompatible polymers, MediVas has developed unique platforms for the delivery of biologics. MediVas is utilizing its novel polymer technology in co...

Relevant Topic

Collaborations in biotechnologyCommercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development.
Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc.
...